Literature DB >> 627833

Migratory behavior of lymphocytes with specific reactivity to alloantigens. II. Selective recruitment to lymphoid cell allografts and their draining lymph nodes.

E E Emeson.   

Abstract

A dual-antigen, dual-isotope assay has been used to monitor the migratory behavior of selectively labeled antiallogeneic lymphocytes in mice challenged subcutaneously in all four foot pads with semiallogeneic spleen cells. 3H-labeled anti-C3H and 14C-labeled anti-C57BL lymphocytes of DBA/2J origin were pooled and adoptively transferred to multiple groups of previously challenged DBA/2J recipients. In some of the studies, separate groups of recipients were challenged with either CDF or BDF spleen cells in all four paws, whereas in others CDF spleen cells were used to challenge the right paws of each mouse in the group and BDF spleen cells to challenge the left paws of each mouse in the group. At intervals varying from 24 to 96 h after challenge, a subgroup of four mice from each appropriate group was sacrificed and the relative numbers of anti-C3H and anti-C57BL lymphocytes present in the challenged paws, draining lymph nodes, and other tissues of each mouse were inferred from the mean 3H/14C ratios of the respective tissues of that subgroup. The results of these studies firmly establish that specific antiallogeneic lymphocytes are selectively recruited to the paws and draining lymph nodes of mice challenged subcutaneously in the foot pads with semiallogeneic spleen cells and are deleted from their circulating blood and nondraining lymph nodes. A mechanism for antigen-induced selective recruitment and its possible functional significance in tumor immunology are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627833      PMCID: PMC2184091          DOI: 10.1084/jem.147.1.13

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  STUDIES ON THE SPECIFICITY OF THE CELLULAR INFILTRATE IN DELAYED HYPERSENSITIVITY REACTIONS.

Authors:  R T MCCLUSKEY; B BENACERRAF; J W MCCLUSKEY
Journal:  J Immunol       Date:  1963-03       Impact factor: 5.422

2.  Migratory behavior of lymphocytes with specific reactivity to alloantigens. I. Selective recruitment to spleen, bone marrow, and liver after an intravenous challenge.

Authors:  E E Emeson
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  The cellular origin of the lymphochte trap.

Authors:  P Frost; E M Lance
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

4.  Changes in lymphocyte circulation after administration of antigen.

Authors:  R Cahill; J B Hay; H Frost; Z Trnka
Journal:  Haematologia (Budap)       Date:  1974

5.  The kinetics of antigen-reactive cells during lymphocyte recruitment.

Authors:  J B Hay; R N Cahill; Z Trnka
Journal:  Cell Immunol       Date:  1974-01       Impact factor: 4.868

6.  Further evidence for the role of macrophages in the initiation of lymphocyte trapping.

Authors:  P Frost
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

Review 7.  Lymphocyte migration and immune responses.

Authors:  W L Ford
Journal:  Prog Allergy       Date:  1975

Review 8.  Immunologic approaches to the diagnosis of cancer.

Authors:  R B Herberman
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

9.  The immunologically specific retention of recirculating long-lived lymphocytes in lymph nodes stimulated by xenogeneic erythrocytes.

Authors:  D R Thursh; E E Emeson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats.

Authors:  D A Rowley; J L Gowans; R C Atkins; W L Ford; M E Smith
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  10 in total

1.  Induction of immunological memory in the skin. Role of local T cell retention.

Authors:  R J Scheper; M von Blomberg; G H Boerrigter; D Bruynzeel; A van Dinther; A Vos
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

2.  Characteristics and functions of Sendai virus-specific T-cell clones.

Authors:  H C Ertl; R W Finberg
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

3.  Role of autologous lymphocyte cytotoxicity in colonic neoplasia.

Authors:  P Gallagher; B M Vose; M Moore; P F Schofield
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

4.  Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes.

Authors:  M R McDermott; P L Brais; G C PLoettsche; M J Evelegh; C H Goldsmith
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Interferon inhibits the generation of allospecific suppressor T lymphocytes.

Authors:  D Fradelizi; I Gresser
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

6.  Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity.

Authors:  A Nemlander; A Soots; E von Willebrand; B Husberg; P Hayry
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

7.  Specific selection of antigen-reactive lymphocytes into antigenically stimulated lymph nodes in sheep.

Authors:  J Hopkins; I McConnell; P J Lachmann
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

8.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

9.  Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth.

Authors:  J P Chandler; T J Yang
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

10.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.